Moderna
MRNA
#267
Rank
NZ$161.07 B
Marketcap
NZ$403.46
Share price
2.49%
Change (1 day)
826.96%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$161.07 Billion

As of November 2026 Moderna has a market cap of NZ$161.07 Billion. This makes Moderna the world's 267th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$161.07 B665.22%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Nov 1st, 2026 the market cap of Moderna was reported to be:

NZ$157.15 Billion
by Nasdaq info icon info icon
NZ$157.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.147 T 612.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$539.37 B 234.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$652.45 B 305.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$1.00 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.28 B-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.47 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$38.19 B-76.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$15.02 B-90.67%๐Ÿ‡บ๐Ÿ‡ธ USA